|
|
Volumn 12, Issue 4, 2006, Pages 137-239
|
|
Role of thiamine in managing ifosfamide-induced encephalopathy
a
|
|
Author keywords
Ifosfamide; Ifosfamide induced encephalopathy; Methylene blue; Thiamine
|
|
Indexed keywords
DOXORUBICIN;
IFOSFAMIDE;
METHYLENE BLUE;
THIAMINE;
ALKYLATING AGENT;
VITAMIN B COMPLEX;
ADULT;
AGED;
AGITATION;
ARTICLE;
AUDITORY HALLUCINATION;
BRAIN DISEASE;
CASE REPORT;
CHEMOPROPHYLAXIS;
CHONDROSARCOMA;
CONFUSION;
DELIRIUM;
DISEASE DURATION;
DISORIENTATION;
DRUG EFFICACY;
DRUG EXPOSURE;
DRUG FATALITY;
DRUG INDUCED DISEASE;
DRUG INFUSION;
DRUG MEGADOSE;
DRUG SAFETY;
DRUG USE;
DRUG WITHDRAWAL;
FEMALE;
HUMAN;
MALE;
MULTIPLE CYCLE TREATMENT;
NEUROTOXICITY;
OSTEOSARCOMA;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
SARCOMA;
SIDE EFFECT;
SOFT TISSUE SARCOMA;
SOMNOLENCE;
TREMOR;
VISUAL HALLUCINATION;
MIDDLE AGED;
TOXICITY AND INTOXICATION;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS, ALKYLATING;
FEMALE;
HUMANS;
IFOSFAMIDE;
MALE;
MIDDLE AGED;
NEUROTOXICITY SYNDROMES;
THIAMINE;
TREATMENT OUTCOME;
VITAMIN B COMPLEX;
|
|
EID: 33846208731
PISSN: 10781552
EISSN: None
Source Type: Journal
DOI: 10.1177/1078155206073553 Document Type: Article |
|
Times cited : (40)
|
|
References (8)
|
